PALOVAROTENE-4 mg ( DrugBank: Palovarotene )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 272 | Fibrodysplasia ossificans progressiva | 1 |
272. Fibrodysplasia ossificans progressiva
Clinical trials : 39 / Drugs : 38 - (DrugBank : 7) / Drug target genes : 27 - Drug target pathways : 95
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2017-002541-29-IT (EUCTR) | 15/03/2018 | 26/01/2021 | A clinical trial to evaluate the Efficacy and Safety of Oral Palovarotene as a treatment for Fibrodysplasia Ossificans Progressiva (FOP) | A Phase 3, Efficacy and Safety Study of Oral Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP) - MOVE Trial | Fibrodysplasia Ossificans Progressiva (FOP) MedDRA version: 20.0;Level: PT;Classification code 10068715;Term: Fibrodysplasia ossificans progressiva;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05] | Trade Name: not applicable Product Name: PALOVAROTENE Product Code: not assigned INN or Proposed INN: Palovarotene Other descriptive name: PALOVAROTENE Trade Name: not applicable Product Name: PALOVAROTENE 1.5 mg Product Code: [not applicable] INN or Proposed INN: PALOVAROTENE Other descriptive name: Palovarotene Trade Name: not applicable Product Name: PALOVAROTENE-2 mg Product Code: [not assigned] INN or Proposed INN: PALOVAROTENE Other descriptive name: Palovarotene Trade Name: not applicable Product Name: PALOVAROTENE Product Code: [not applicable] INN or Proposed INN: PALOVAROTENE Other descriptive name: palovarotene Trade Name: not applicable Product Name: PALOVAROTENE-3 mg Product Code: [not applicable] INN or Proposed INN: PALOVAROTENE Other descriptive name: Palovarotene Trade Name: not applicable Product Name: PALOVAROTENE-4 mg | CLEMENTIA PHARMACEUTICALS INC. | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 107 | Phase 3 | United States;Spain;Korea, Democratic People's Republic of;Russian Federation;United Kingdom;Italy;France;Canada;Argentina;Brazil;Australia;South Africa;Netherlands;Germany;Japan;Sweden;Korea, Republic of |